ULTRAGENYX PHARMACEUTICALS INC (RARE) Covered Calls

ULTRAGENYX PHARMACEUTICALS INC covered calls Ultragenyx Pharmaceutical Inc is a development-stage biopharmaceutical company engaged in identifying, acquiring, developing and marketing novel products for the treatment of rare and ultra-rare disease.

You can sell covered calls on ULTRAGENYX PHARMACEUTICALS INC to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for RARE (prices last updated Mon 4:16 PM ET):

ULTRAGENYX PHARMACEUTICALS INC (RARE) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
84.35 -0.21 82.79 84.99 385K - 4.2B
Covered Calls For ULTRAGENYX PHARMACEUTICALS INC (RARE)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Jul 20 85 1.05 83.94 1.3% 94.9%
Aug 17 85 4.40 80.59 5.5% 60.8%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Ultragenyx Pharmaceutical, Inc. is a clinical-stage biotechnology company. The company is focused on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare diseases, with an initial focus on serious, debilitating metabolic genetic diseases. It intends to build therapies to address these clinically underserved diseases. Ultragenyx Pharmaceutical was founded by Emil D. Kakkis on April 22, 2010 and is headquartered in Novato, CA.